Analysed KALA BIO INC (KALA:NASDAQ) News Sources
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
29-09-2026
yahoo.com
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
01-04-2026
yahoo.com
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
21-04-2026
yahoo.com
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
30-03-2026
yahoo.com
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
01-09-2026
yahoo.com
Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership
01-09-2026
advfn.com
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
03-09-2026
yahoo.com
Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests
03-09-2026
advfn.com
What is the current price of KALA BIO INC (KALA:NASDAQ)?
The current price of KALA BIO INC (KALA:NASDAQ) is $0.1862.
KALA BIO INC (KALA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KALA BIO INC (KALA:NASDAQ) since the previous trading day is $-0.0039.
KALA BIO INC (KALA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KALA BIO INC (KALA:NASDAQ) since the previous trading day is -2.0516%.
What is the most recent average sentiment score for KALA BIO INC (KALA:NASDAQ)?
The most recent average sentiment score for KALA BIO INC (KALA:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for KALA BIO INC (KALA:NASDAQ)?
The most recent sentiment for KALA BIO INC (KALA:NASDAQ) is .
SEC-8K** Filing Available For KALA BIO INC (KALA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.